Detection of hepatitis C virus RNA in alpha interferon derived from in vitro culture of leukocytes of human origin

Biologicals

Volumn 29, Issue 1, 2001, Pages 45-53

  Forcic D ^a   Zgorelec, R ^a   Santak M ^a   Kosutic T ^a   Mazuran R ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ACIDIFICATION; ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENDAI VIRUS; SEROLOGY; VIRUS DETECTION;

EID: 0034898185     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2001.0275     Document Type: Article

References (44)

1. Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis
2. The molecular virology of hepatitis C
3. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups
4. Variability of hepatitis C virus
5. Detection of hepatitis C virus RNA by in situ hybridization: A critical appraisal
6. Detection of replicative forms of hepatitis C virus RNA in peripheral blood mononuclear cells
7. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients
8. Lymphotropism of hepatitis B and C viruses: An update and a newcomer
9. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication
10. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus
11. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells
12. Replication of hepatitis C virus in B lymphocytes (CD19+)
13. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype
14. Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR
15. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation
16. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients
17. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
18. Large-scale HCV. RNA screening in first-time blood donors: The first step towards genomic screening of blood donations
19. Sendai virus induces various cytokines in primary cultures of peripheral human leukocytes
20. Production of interferon in human leukocytes from normal donors with the use of Sendai virus
21. Single-step method of total RNA isolated by acid guanidine-phenol extraction
22. Avoiding false positives with PCR
23. Quality control of the polymerase chain reaction
24. A sensitive PCR assay for the quantitation of viral genome equivalents: Hepatitis C virus (HCV)
25. Hepatitis: Global prevalence
26. Standardisation: A progress report
27. Hepatitis C virus (HCV) specific sequences are demonstrable in the DNA fraction of peripheral blood mononuclear cells from healthy, anti-HCV antibody-negative individuals and cell lines of human origin
28. Hepatitis C virus-specific DNA sequences in human DNA: Differentiation by means of restriction enzyme analysis at the DNA level in healthy, anti-HCV-negative individuals
29. Preliminary results of transmission experiments of non-A, non-B hepatitis by mononuclear leucocytes from a chronic patient
30. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication
31. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus
32. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis
33. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma and peripheral blood mononuclear cells
34. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fraction: Plasma HCV RNA analysis underestimates circulating virus load
35. Detection of hepatitis C virus (HCV) in liver tissue of HCV-RNA seronegative patients by means of anti-HCV-antibodies and RT-PCR
36. Comparison of whole blood and serum for the detection of hepatitis C virus (HCV) RNA in interferon (IFN) treated patients
37. Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: Improved detection using whole blood as the source of viral RNA
38. Specific binding of hepatitis C virus to the Fc fragment of immunoglobulin molecules
39. Density heterogeneities of hepatitis C virus in human sera due to binding of beta-lipoproteins and immunoglobulins
40. The role of interferons in the regulation of cell function and in the pathogenesis of disease
41. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing usinga mutant Taq DNA polymerase
42. Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis